Filing Details
- Accession Number:
- 0001209191-17-053149
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-18 16:09:23
- Reporting Period:
- 2017-09-14
- Accepted Time:
- 2017-09-18 16:09:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1180432 | John Maraganore | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-14 | 18,868 | $2.09 | 24,711 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-14 | 18,268 | $131.19 | 6,443 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-09-14 | 600 | $131.82 | 5,843 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Commonstock | Stock Option (right to buy) | Acquisiton | 2017-09-14 | 18,868 | $0.00 | 18,868 | $2.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-01-08 | No | 4 | M | Direct |
Footnotes
- The range in prices for the transaction reported on this line was $130.80 to $131.75. The average weighted price was $131.1935. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $131.80 to $131.90. The average weighted price was $131.8167. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests in 48 equal monthly installments, commencing on April 1, 2011.
Billionaire Hedge Funds
